期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性肾脏病患者高血压的治疗 被引量：2

下载PDF
导出
摘要 高血压作为传统的心血管病危险因素,在慢性肾脏病（chronic kidney disease,CKD）-心血管疾病轴的发展中起着重要作用[1]。高血压在CKD患者中的发病率高、控制率低。高血压既是导致CKD的主要病因,
作者 任伟 王艳
机构地区 安徽医科大学附属省立医院肾内科
出处 《安徽医学》 2012年第3期366-367,共2页 Anhui Medical Journal
关键词 高血压 慢性肾脏病 药物治疗 血液透析
分类号 R692.3 [医药卫生—泌尿科学] R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献12

  • 1David S,Haller H,Kümpers P. The angiopoietin/Tie-2 axis:a novel player in chronic kidney disease[J].Minerva Urologica E Nefrologica,2010,(03):319-326.
  • 2Soucek M,Monhart V,Nedbálková M. Hypertension and cardiovascular complications of chronic renal failure[J].Vnitrni Lekarstvi,2011,(7-8):615-619.
  • 3Wilhelm-Leen ER,Hall YN,K Tamura M. Frailty and chronic kidney disease:the Third National Health and Nutrition Evaluation Survey[J].American Journal of Medicine,2009,(07):664-671.
  • 4Appel LJ,Wright JT J r,Greene T. Intensive blood-pressure control in hypertensive chronic kidney disease[J].New England Journal of Medicine,2010,(10):918-929.
  • 5黄文胜,杜礼兵,冷利华.厄贝沙坦对高血压患者尿微量蛋白排泄的影响[J].安徽医学,2009,30(12):1460-1461. 被引量：4
  • 6Baltatzi M,Savopoulos C h,Hatzitolios A. Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection.Study results[J].Hippokratia,2011,(Suppl 1):27-32.
  • 7Trimarchi H. Role of aliskiren in blood pressure control and renoprotection[J].Int J Nephrol Renovasc Dis,2011.41-48.
  • 8Dimkovi N,Dimkovi S. Renoprotective effect of calcium channel blockers[J].Srpski Arhiv Za Celokupno Lekarstvo,2009,(11-12):690-696.
  • 9Lardizabal JA,Deedwania PC. The current state of beta blockers in hypertension therapy[J].Indian Heart Journal,2010,(02):111-117.
  • 10Adhikary L,Koirala A,Gautam B. Effective control of hypertension in adults with chronic kidney disease[J].JNMA J Nepal Med Assoc,2010,(180):291-294.

二级参考文献9

  • 1薛晶,陈丹,张慧,覃湘林,李玉璞.高血压患者尿微量蛋白早期检测意义及苯那普利对其影响[J].第四军医大学吉林军医学院学报（86813X）,2002,24(2):77-79. 被引量：2
  • 2T. Deckert,B. Feldt-Rasmussen,K. Borch-Johnsen,T. Jensen,A. Kofoed-Enevoldsen.Albuminuria reflects widespread vascular damage[J]. Diabetologia . 1989 (4)
  • 3VIBERTI GC,HILL RD,JARRETT RJ,et al.Microalbuminuria as a predictor of clinical nephropathy in insulin - dependent diabetes mellitus. The Lancet . 1982
  • 4Viberti,GC,Jarrett,RJ,Keen,H.Microalbuminuria as prediction of nephropathy in diabetics. The Lancet . 1982
  • 5Kannel,WB,Stampfer,MJ,Castelli,WP.The prognostic significance of proteinuria. American Heart Journal . 1984
  • 6Deckert T,Feldt-Rasmussen B,Borch-Johnsenk,et al.Albuminuri-a refects widespread vascular damage.The Steno hypothesis. Diabetogia . 1989
  • 7Hayden MR,Kolb L,Chowdbury N,et al.Detecting microalbuminuriaand taking action in the cardiometabolic syndrome and type 2 diabetesmellitus. Molecular Medicine . 2006
  • 8Ruggenenti P,Schieppati A,Remuzzi G.Progression, remission, regression of chronic renal dis-ease. The Lancet . 2001
  • 9应之和,徐耕.不同剂量缬沙坦对高血压病患者尿微量蛋白的影响[J].心脑血管病防治,2001,1(2):13-15. 被引量：2

共引文献3

同被引文献34

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量：136
  • 2谌贻璞,王海燕.迎接“世界肾脏日”:重视慢性肾脏病的早期诊断与防治[J].中华医学杂志,2006,86(10):649-651. 被引量：16
  • 3Kearney PM, Whelton M, Reynolds K, et al. Global burden of hy- pertension: analysis of worldwide data [J]. Lancet, 2005, 365: 217-223.
  • 4Xu JL, Ma .TZ, Louis TA, et al. Forecast of the number of patients with end--stage renal disease in the United States to the year 2010 [J]. J Am Soc Nephrol, 2001, 12: 2753-2758.
  • 5Zhang LX, Zou L, Xu GB, et al. Community-based screening for chronic renal disease among populations older than 40 years in Bei- jing [J]. Nephrol Dial Transplant, 2007, 22(9): 1093-1099.
  • 6Chcn N, Wang W, Huang Y. Community-based study on CKD sub- jccts and the associated risk factors [J]. Nclahrol Dial Transplant, 2009, 24(16): 2117-2119.
  • 7Wilhelm-leen ER, Hall YN, Tamura MK, et al. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Suevey [J]. Am J Med, 2009, 122 (7): 664-671.
  • 8Khosla N, Kalaitzi dis R, Bakfis GL. The kidney, hypertension, and remaining challenges [J]. Med Clin North Am, 2009, 93:697-715.
  • 9Khan NA, Hemmelgarn B, Herman RJ, et al. The 2009 Canadian Hypertension Education Program recommendations for the manage- merit of hypertension: Part 2--therapy [J]. Can J Cardiol, 2009, 25 (5): 287-298.
  • 10Raj T. Hypertension And Renal Disease [J]. Medicine, 2011, 39(6): 362-363.

引证文献2

二级引证文献26

安徽医学
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部